Skip to main content

Published locations for FDA panel supports approval of flibanserin for hypoactive sexual desire

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA panel supports approval of flibanserin for hypoactive sexual desire

User login

  • Reset your password
  • /content/fda-panel-supports-approval-flibanserin-hypoactive-sexual-desire
  • /familypracticenews/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive
  • /internalmedicinenews/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive
  • /obgynnews/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive-sexual-desire
  • /clinicalendocrinologynews/article/100221/gynecology/fda-panel-supports-approval-flibanserin
  • /psychiatry/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive-sexual
  • /obgyn/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive-sexual-desire
  • /endocrinology/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive-sexual
  • /internalmedicine/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive-sexual
  • /familymedicine/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive-sexual
  • /clinicalpsychiatrynews/article/100221/gynecology/fda-panel-supports-approval-flibanserin-hypoactive